Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to evaluate the efficacy of glyceroltrinitrate (Nitroderm® TTS) to activate and expand human BAT as compared to mild cold exposure.


Clinical Trial Description

The activation of brown adipose tissue in response to glyceroltrinitrate as compared to cold exposure will be studied in an open-label, cross-over trial in healthy volunteers with random sequence of the two study periods (treatment and control) seperated by a washout period of 7 days. In the treatment phase all participants will receive Nitroderm® TTS (glyceroltrinitrate) for a total of 15 days. For better tolerability, it will be will started with a lower dose of 5mg/24h (Nitroderm® TTS) the first 5 days and after that a change to Nitroderm® TTS 10mg/24h for another 10 days will be done. Each transdermal patch will be applied for 12 hours per day (overnight) to avoid development of nitrate tolerance. Energy expenditure will be measured by indirect calorimetry before and after a mild cold exposure by placing a medical cooling system around their midsection. Additionally brown adipose tissue activity will determined by 18F-FDG-PET/CT 30 min after injection of 75 MBq of 18F-FDG. To analyse changes in BAT and muscle which are caused by glyceroltrinitrate as compared with cold stimulus, a tissue biopsie of supraclavicular BAT and skeletal muscle (musculus vastus lateralis) will be performed. To measure changes in glucose tolerance and triglyceride levels a mixed meal test will be performed during control and treatment phase respectively. Additionally, a indirect calorimetry will be conducted before and after mixed meal test to assess diet-induced thermogenesis, i.e. the increase in REE due to ingestion of nutrients In control phase the same examinations will be performed, but without glyceroltrinitrat. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05711199
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact Matthias J Betz, MD
Phone 0041 61 556 56 54
Email matthias.betz@usb.ch
Status Recruiting
Phase Early Phase 1
Start date March 1, 2023
Completion date August 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT02038595 - The Norepinephrine Transporter: A Novel Target for Imaging Brown Adipose Tissue Early Phase 1
Completed NCT02964442 - Brown Adipose Tissue Activation and Energy Expenditure by Capsinoids Stimulation With Trimodality Imaging Using 18-FDG-PET, Fat Fraction MRI and Infrared Thermography N/A
Recruiting NCT06078345 - Brown Adipose Tissue as Nutrient Buffer Through Diet Induced Thermogenesis N/A
Active, not recruiting NCT03541096 - Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT). N/A
Completed NCT04766021 - Mirabegron and Physiological Function in Cold Environments Phase 1/Phase 2
Completed NCT01898949 - Stimulation of Diet-Induced Thermogenesis by Cold-Exposure N/A
Completed NCT05990387 - MIrabegron and Physiological Function in Cold Environments Phase 1/Phase 2
Recruiting NCT04595006 - Brown Fat Activation and Browning Efficiency Augmented by Chronic Cold and Nutraceuticals for Brown Adipose Tissue-mediated Effect Against Metabolic Syndrome (BEACON BEAMS Study) N/A
Completed NCT02381483 - Vitamin A in Brown Fat Activity N/A
Completed NCT03269747 - Short Term Effect of Glucocorticoids on Brown Adipose Tissue Thermogenesis in Humans Phase 4
Recruiting NCT05517967 - An Examination of Brown Adipose Tissue and Energy Expenditure in Infants
Completed NCT03490227 - Measurement of Body Fat in Infants
Completed NCT03096535 - Cold Induced Activation of Brown Adipose Tissue in Humans N/A
Completed NCT03095846 - Cold Induced Activation of Brown Adipose Tissue in Winter Swimmers N/A